Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | RA CAPITAL MANAGEMENT L.P. | 2,150,404 5.400% | 2,150,404 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | PANDION THERAPEUTICS INC PAND | RA CAPITAL MANAGEMENT L.P. | 1,770,023 6.000% | 1,770,023 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Milestone Pharmaceuticals Inc. MIST | RA CAPITAL MANAGEMENT L.P. | 2,327,714 7.800% | 2,327,714 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Defiance Trillion Dollar Club Index ETF TRIL | RA CAPITAL MANAGEMENT L.P. | 5,290,481 5.300% | 5,290,481 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Ardelyx, Inc. ARDX | RA CAPITAL MANAGEMENT L.P. | 24,652,344 6.800% | 2,543,992 (+11.51%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | ChemoCentryx, Inc. CCXI | RA CAPITAL MANAGEMENT L.P. | 4,776,548 6.900% | 1,577,159 (+49.30%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | ARYA SCIENCES ACQUISITION CORP ARYA | RA CAPITAL MANAGEMENT L.P. | 1,000,000 6.700% | 1,000,000 (New Position) | Filing History |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Crinetics Pharmaceuticals, Inc. CRNX | RA CAPITAL MANAGEMENT L.P. | 564,102 1.700% | -1,311,107 (-69.92%) | Filing History |
| 2021-02-16 4:39 pm Sale | 2020-12-31 | 13G | Vaxcyte, Inc. PCVX | RA CAPITAL MANAGEMENT L.P. | 3,710,699 7.300% | -1,778,482 (-32.40%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | RA CAPITAL MANAGEMENT L.P. | 3,825,008 12.300% | 178,200 (+4.89%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Zogenix, Inc. ZGNX | RA CAPITAL MANAGEMENT L.P. | 5,345,631 9.600% | 3,084,880 (+136.45%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | scPharmaceuticals Inc. SCPH | RA CAPITAL MANAGEMENT L.P. | 3,518,998 12.900% | 271,993 (+8.38%) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | BCLS Acquisition Corp. BLSA | RA CAPITAL MANAGEMENT L.P. | 1,250,000 8.400% | 1,250,000 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | 5:01 Acquisition Corp. FVAM | RA CAPITAL MANAGEMENT L.P. | 750,000 8.700% | 750,000 (New Position) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | ARS Pharmaceuticals, Inc. SPRY | RA CAPITAL MANAGEMENT L.P. | 1,742,186 5.000% | 1,742,186 (New Position) | Filing History |
| 2021-02-16 4:34 pm Purchase | 2020-12-31 | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT L.P. | 41,543,004 9.990% | 41,543,004 (New Position) | Filing History |
| 2021-02-11 4:46 pm Sale | 2021-02-09 | 13G | Iterum Therapeutics plc ITRM | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -915,358 (Position Closed) | Filing History |
| 2021-02-10 4:49 pm Sale | 2021-01-31 | 13G | TG Therapeutics, Inc. TGTX | RA CAPITAL MANAGEMENT L.P. | 6,361,123 4.700% | -6,427,334 (-50.26%) | Filing History |
| 2021-02-10 4:48 pm Sale | 2021-01-31 | 13G | Keros Therapeutics, Inc. KROS | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -1,875,000 (Position Closed) | Filing History |
| 2021-02-10 4:47 pm Sale | 2021-01-31 | 13G | Arvinas, Inc. ARVN | RA CAPITAL MANAGEMENT L.P. | 0 0.000% | -3,672,872 (Position Closed) | Filing History |